Results 71 to 80 of about 860,145 (127)

Real-World Pharmacovigilance Analysis of Adverse Events Associated with Liposomal Bupivacaine and Bupivacaine. [PDF]

J Pain Res
Chen DX, Chen XM, Chen SM, Wang YD.
europepmc   +1 more source

Clinical pharmacology in health care service [PDF]

Vojnosanitetski Pregled, 2005
Janković Slobodan M.
doaj   +1 more source

A retrospective research of adverse event reporting system events for voxelotor based on the FAERS database. [PDF]

BMC Pharmacol Toxicol
Lin Y, Li H, Dong Y, Fang W, Huang H, He M, Zhou X, Sun N.   +7 more
europepmc   +1 more source

Probing the in-depth analysis of Serious Adverse Drug Reactions in a tertiary care hospital of Central India. [PDF]

Explor Res Clin Soc Pharm
Singh P, Verma S, Vaishnav Y, Joshi U, Agrawal M.   +4 more
europepmc   +1 more source

Empowering Patient Safety: Assessment of Adverse Drug Reaction Knowledge and Practice Among Pharmacy Professionals. [PDF]

Pharmacy (Basel)
Bukić J, Leskur D, Durdov T, Božić J, Modun D, Šešelja Perišin A, Ančić D, Šepetavc M, Mihanović A, Rušić D.   +9 more
europepmc   +1 more source

Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data. [PDF]

BMC Med
Massy M, Marti S, Hammer H, Hoepner R.
europepmc   +1 more source

Employing bibliometrics and natural language processing (NLP) to analyse real-world applications of adverse drug reaction. [PDF]

Explor Res Clin Soc Pharm
Dsouza VS, Leyens L, Brand A.
europepmc   +1 more source

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system. [PDF]

BMC Cancer
Gao R, Liang W, Chen J, Yang M, Yu X, Wang X.   +5 more
europepmc   +1 more source

Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning. [PDF]

Pharmaceuticals (Basel)
Toriumi S, Shimokawa K, Yamamoto M, Uesawa Y.   +3 more
europepmc   +1 more source

Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance. [PDF]

Alzheimers Res Ther
Donati M, Boccia A, De Ponti F, Poluzzi E, Raschi E.   +4 more
europepmc   +1 more source